Global Synthetic Biology Market – Focused Insights 2024-2029

THE GLOBAL SYNTHETIC BIOLOGY MARKET WAS VALUED AT USD 15.20 BILLION IN 2023 AND IS EXPECTED TO REACH USD 59.91 BILLION BY 2029, GROWING AT A CAGR OF 25.68% DURING FORECAST PERIOD.

Global Synthetic Biology Market Size Report

Synthetic Biology Market Size, Share, Growth, Trend Analysis Report By Tool (Enzymes, Cloning Technology Kits, Synthetic DNA), By Technology, By Application, By End-User, By Geography, Industry Forecast Report 2024-2029

158 pages

11 tables

38 charts

5 region

18 countries

38 company

5 segments

Purchase Options

$2990
$3500
$4500
$2000

Global Synthetic Biology Market – Focused Insights 2024-2029

THE GLOBAL SYNTHETIC BIOLOGY MARKET WAS VALUED AT USD 15.20 BILLION IN 2023 AND IS EXPECTED TO REACH USD 59.91 BILLION BY 2029, GROWING AT A CAGR OF 25.68% DURING FORECAST PERIOD.

The Synthetic Biology Market Size, Share & Trend Analysis Report By

  1. Tool: Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Xeno-Nucleic Acids, and Chassis Organisms
  2. Technology: Enabling Technology and Enabled Technology
  3. Application: Healthcare Application, Industrial Application, Food & Agriculture Application, and Environmental Application
  4. End-User: Academic/Research Institutes & Laboratories, Pharma & Biotech Companies, and Others
  5. Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

GLOBAL SYNTHETIC BIOLOGY MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2029)USD 59.91 Billion
Market Size (2023)USD 15.20 Billion
CAGR (2023-2029)25.68%
HISTORIC YEAR2020-2022
BASE YEAR2023
FORECAST YEAR2024-2029
MARKET SEGMENTS BYTool, Technology, Application, End-User, and Geography
GEOGRAPHIC ANALYSISNorth America, Europe, APAC, Latin America, and Middle East & Africa
KEY PLAYERSAgilent Technologies, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific
Interested in this Report?

SYNTHETIC BIOLOGY MARKET SIZE

The global synthetic biology market size was valued at USD 15.20 billion in 2023 and is expected to reach USD 59.91 billion by 2029, growing at a CAGR of 25.68% during the forecast period.

The global synthetic biology market is a thriving hub of innovation, led by giants like Agilent Technologies, Thermo Fisher Scientific, and Illumina, who are constantly evolving to maintain their competitive edge. Through bold R&D investments, new product launches, and strategic patents, these leaders drive advancements across healthcare, agriculture, industry, and environmental sectors. Yet, the market’s vibrancy doesn’t stop there—emerging players are making waves with groundbreaking tools and niche solutions to boom in the market.

Strategic Initiatives and New Collaborations in the Synthetic Biology Market 

Novozymes and Codexis are actively pursuing strategic initiatives to bolster their market presence, including the launch of new products and fostering collaborative efforts. Similarly, Agilent Technologies and Eurofins Scientific are key players focusing on introducing new products in targeted regions to increase their global market share. 

In 2023, Sumitomo Chemical and Ginkgo Bioworks launched a new initiative to utilize synthetic biology to produce functional chemicals, marking their third collaborative project. Since 2021, the two companies have worked together on biomanufacturing solutions for personal care, cosmetics, agriculture, and pharmaceuticals. Their latest project is aimed at enabling large-scale production of functional chemicals through fermentation. 

Synthetic Biology Trends Driving Market Growth

Advances in synthetic biology platforms, metabolic engineering, and gene synthesis are reshaping industries. From genetically engineered crops and biofuels to personalized medicine and multiplexed diagnostics, synthetic biology enables precise biological design. Companies like Impossible Foods exemplify this transformation by creating plant-based meat using synthetic biology techniques, showcasing the growing synthetic genes market.

Sustainability and Bio-Based Innovation

The synthetic biology market forecast anticipates strong momentum as the demand for bio-based products and sustainable energy solutions rises. Innovations in microbial engineering allow the conversion of renewable resources into high-value chemicals and fuels, reducing reliance on fossil fuels and promoting environmental sustainability.

Applications in Healthcare and Therapeutics

The healthcare segment leads the synthetic biology market share, especially in therapeutic genome editing and CRISPR-based diagnostics. With synthetic biology enabling tailored treatments and fast, accurate disease detection, its integration into personalized medicine and next-gen vaccines is accelerating.

Challenges and Market Restraints

Despite growth, the industry faces challenges such as regulatory hurdles, high R&D costs, and potential disruption to existing technologies. Emerging economies are catching up in innovation, but biology market research shows patent dominance in high-income countries like the U.S. and the U.K.

Synthetic Biology Market Segmentation

Tool Insights

  1. Oligonucleotides & Synthetic DNA lead the market due to widespread use in PCR, sequencing, and diagnostics.
  2. Rapid growth is driven by next-gen DNA synthesizers enabling precision gene design and novel therapeutics.

Technology Insights

  1. Enabling technologies (gene synthesis, bioinformatics, genome engineering) show the fastest growth.
  2. Core to synthetic biology innovation across healthcare, agriculture, and biotech.

Application Insights

  1. Healthcare dominates with applications in immunology, cancer, genetics, and neuroscience.
  2. Synthetic biology tools are revolutionizing personalized medicine and advanced diagnostics.

End-User Insights

  1. Pharma & biotech companies lead adoption for drug development and biosynthetic applications.
  2. Focus on small-molecule drugs, microbial production, and R&D-driven innovations.

Regional Outlook

North America Synthetic Biology Trends

North America dominates the global synthetic biology market, supported by leading R&D infrastructure and high adoption of cell and gene therapies. The region is home to over 530 regenerative medicine companies, making it a hub for innovation and clinical advancement.

Synthetic Biology Market Vendor Insights

According to the latest synthetic biology market report, major players include Agilent Technologies, Thermo Fisher Scientific, Illumina, Codexis, Eurofins Scientific, and Novozymes. These companies drive competition through innovation, strategic partnerships, and consistent product development in healthcare, agriculture, and environmental applications.

Europe Synthetic Biology Trends

Europe stands as a key global player in the life sciences, ranking just behind North America in fields like synthetic biology, genome sequencing, and cell and gene therapy. This leadership is supported by a strong research and development infrastructure capable of handling complex sequencing and data analysis tasks. The widespread adoption of next-generation sequencing (NGS) and synthetic biology tools across European countries reflects a deep commitment to technological innovation.

The European Synthetic Biology Society (EUSynBioS) plays a vital role in connecting researchers and promoting collaboration between academia and industry. Governments across the continent are increasing investments in synthetic biology to drive economic growth and address strategic challenges in areas such as agriculture, energy, and defense.

The UK, in particular, leads in this space thanks to its skilled workforce and advanced research infrastructure, attracting significant investment. Europe also leverages synthetic biology for sustainability, using it to convert waste into useful materials and reduce environmental impact, aligning science with green goals.

The Synthetic Biology Market Report Addresses: 

  1. Comprehensive Market Intelligence to support informed and strategic decision-making. 
  2. Market Size Estimation and Forecasts from 2020 to 2029 for actionable future planning. 
  3. Identification of Growth Opportunities and Emerging Trends to leverage market potential. 
  4. Detailed Segment and Regional Revenue Projections for accurate market assessment. 
  5. Competitive Landscape Analysis, including strategic insights and market share evaluation. 
  6. Innovative Product Developments and Launches to help you stay ahead in a dynamic market. 

SNAPSHOT

The global synthetic biology market size is expected to grow at a CAGR of approximately 25.68% from 2023 to 2029.

Base Year: 2023

Forecast Year: 2024-2029

The report considers the present scenario of global synthetic biology and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

SYNTHETIC BIOLOGY MARKET VENDORS

Key Vendors

  1. Agilent Technologies
  2. Business Overview
  3. Product Offerings
  4. Codexis
  5. Eurofins Scientific
  6. Illumina
  7. Novozymes
  8. Thermo Fisher Scientific

Other Prominent Vendors

  1. Amyris
  2. Business Overview
  3. Product Offerings
  4. ATUM
  5. Bio-Rad Laboratories
  6. Creative Biogene
  7. Creative Enzymes
  8. Cyrus Biotechnology
  9. Editas Medicine
  10. Genomatica
  11. Genscript
  12. Ginkgo Bioworks
  13. Integrated DNA Technologies
  14. LGC Biosearch Technologies
  15. New England Biolabs
  16. OriGene Technologies
  17. Precigen
  18. Sentebiolab
  19. SynbiCITE
  20. Synthego
  21. Tessera Therapeutics
  22. Viridos
  23. Asimov
  24. Twist Bioscience
  25. Mammoth Biosciences
  26. ElevateBio
  27. Dupont
  28. DSM
  29. Bota Biosciences
  30. Kiverdi
  31. Merck KGaA
  32. Synlogic
  33. Huee
  34. Upside Foods

SEGMENTATION & FORECAST

  1. By Tool
  2. Oligonucleotides and Synthetic DNA
  3. Enzymes
  4. Cloning Technology Kits
  5. Xeno-Nucleic Acids
  6. Chassis Organisms
  7. By Technology
  8. Enabling Technology
  9. Enabled Technology
  10. By Application
  11. Healthcare Application
  12. Industrial Application
  13. Food & Agriculture Application
  14. Environmental Application
  15. By End-User
  16. Academic/Research Institutes & Laboratories
  17. Pharma & Biotech Companies
  18. Others
  19. By Geography
  20. North America
  21. The U.S.
  22. Canada
  23. Europe
  24. Germany
  25. The U.K.
  26. France
  27. Italy
  28. Spain
  29. APAC
  30. Japan
  31. China
  32. India
  33. Australia
  34. South Korea
  35. Latin America
  36. Brazil
  37. Mexico
  38. Argentina
  39. Middle East & Africa
  40. Turkey
  41. South Africa
  42. Saudi Arabia

Frequently Asked Questions

What are the key drivers of the global synthetic biology market?

Rising demand for DNA sequencing, the surge in synthetic biology investments driven by food and energy sectors, and the increasing number of start-ups boosting the demand are the key drivers of the global synthetic biology market.

How big is the global synthetic biology market?

The global synthetic biology market was valued at USD 15.20 billion in 2023 and is expected to reach USD 59.91 billion by 2029.

Which region dominates the global synthetic biology market?

North America dominates the global synthetic biology market.

What is the growth rate of the global synthetic biology market?

The global synthetic biology market is expected to grow at a CAGR of 25.68% during the forecast period.

Who are the major players in the global synthetic biology market?

Agilent Technologies, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific are the major players in the global synthetic biology market.

Exhibit 1: Projected Revenues of Global Synthetic Biology Market (2020–2029; $ BN)

Exhibit 2: Market Size & Forecast – Oligonucleotides and Synthetic DNA (2020–2029; $ BN)

Exhibit 3: Market Size & Forecast –Enzymes (2020–2029; $ BN)

Exhibit 4: Market Size & Forecast – Cloning Technology Kits (2020–2029; $ BN)

Exhibit 5: Market Size & Forecast – Xeno-Nucleic Acids (2020–2029; $ BN)

Exhibit 6: Market Size & Forecast – Chassis Organisms (2020–2029; $ BN)

Exhibit 7: Market Size & Forecast – Enabling Technology (2020–2029; $ BN)

Exhibit 8: Market Size & Forecast – Enabled Technology (2020–2029; $ BN)

Exhibit 9: Market Size & Forecast – Healthcare Application (2020–2029; $ BN)

Exhibit 10: Market Size & Forecast – Industrial Application (2020–2029; $ BN)

Exhibit 11: Market Size & Forecast – Food & Agriculture Applications (2020–2029; $ BN)

Exhibit 12: Market Size & Forecast – Environmental Application (2020–2029; $ BN)

Exhibit 13: Market Size & Forecast – Academic/Research Institutes & Laboratories (2020–2029; $ BN)

Exhibit 14: Market Size & Forecast – Pharma & Biotech Companies (2020–2029; $ BN)

Exhibit 15: Market Size & Forecast – Others (2020–2029; $ BN)

Exhibit 16: Projected Revenues of Synthetic Biology in North America (2020–2029; $ BN)

Exhibit 17: Projected Revenues of Synthetic Biology in the US (2020–2029; $ BN)

Exhibit 18: Projected Revenues of Synthetic Biology in Canada (2020–2029; $ BN)

Exhibit 19: Projected Revenues of Synthetic Biology in Europe (2020–2029; $ BN)

Exhibit 20: Projected Revenues of Synthetic Biology in UK (2020–2029; $ BN)

Exhibit 21: Projected Revenues of Synthetic Biology in Germany (2020–2029; $ BN)

Exhibit 22: Projected Revenues of Synthetic Biology in France (2020–2029; $ BN)

Exhibit 23: Projected Revenues of Synthetic Biology in Italy (2020–2029; $ BN)

Exhibit 24: Projected Revenues of Synthetic Biology in Spain (2020–2029; $ BN)

Exhibit 25: Projected Revenues of Synthetic Biology in APAC (2020–2029; $ BN)

Exhibit 26: Projected Revenues of Synthetic Biology in Japan (2020–2029; $ BN)

Exhibit 27: Projected Revenues of Synthetic Biology in China (2020–2029; $ BN)

Exhibit 28: Projected Revenues of Synthetic Biology in South Korea (2020–2029; $ BN)

Exhibit 29: Projected Revenues of Synthetic Biology in Australia (2020–2029; $ BN)

Exhibit 30: Projected Revenues of Synthetic Biology in India (2020–2029; $ BN)

Exhibit 31: Projected Revenues of Synthetic Biology in Latin America (2020–2029; $ BN)

Exhibit 32: Projected Revenues of Synthetic Biology in Brazil (2020–2029; $ BN)

Exhibit 33: Projected Revenues of Synthetic Biology in Mexico (2020–2029; $ BN)

Exhibit 34: Projected Revenues of Synthetic Biology in Argentina (2020–2029; $ BN)

Exhibit 35: Projected Revenues of Synthetic Biology in the MEA (2020–2029; $ BN)

Exhibit 36: Projected Revenues of Synthetic Biology in Turkey (2020–2029; $ BN)

Exhibit 37: Projected Revenues of Synthetic Biology in Saudi Arabia (2020–2029; $ BN)

Exhibit 38: Projected Revenues of Synthetic Biology in South Africa (2020–2029; $ BN)


List of Tables


Table 1: Projected Revenues of Global Synthetic Biology Market (2020–2029; $ BN)

Table 2: Global Synthetic Biology Market by Technology (2020–2029; %)

Table 3: Global Synthetic Biology Market by Technology (2020–2029; $ BN)

Table 4: Global Synthetic Biology Market by Tool (2020–2029; %)

Table 5: Global Synthetic Biology Market by Tool (2020–2029; $ BN)

Table 6: Global Synthetic Biology Market by Application (2020–2029; %)

Table 7: Global Synthetic Biology Market by Application (2020–2029; $ BN)

Table 8: Global Synthetic Biology Market by End-User (2020–2029; %)

Table 9: Global Synthetic Biology Market by End-User (2020–2029; $ BN)

Table 10: Global Synthetic Biology Market by Geography (2020–2029; %)

Table 11: Global Synthetic Biology Market by Geography (2020–2029; $ BN)

CHAPTER – 1: Synthetic Biology Market Overview

  1. Executive Summary
  2. Key Findings


CHAPTER – 2: Synthetic Biology Market

  1. GLOBAL: Projected Revenue of Synthetic Biology Market (2020-2029; $Billions)


CHAPTER – 3: Synthetic Biology Market Segmentation Data

  1. GLOBAL: Projected Revenue by Tool (2020-2029; $Billions)
  2. Oligonucleotides and Synthetic DNA
  3. Enzymes
  4. Cloning Technology Kits
  5. Xeno-Nucleic Acids
  6. Chassis Organisms
  7. GLOBAL: Projected Revenue by Technology (2020-2029; $Billions)
  8. Enabling Technology
  9. Enabled Technology
  10. GLOBAL: Projected Revenue by Application (2020-2029; $Billions)
  11. Healthcare Application
  12. Industrial Application
  13. Food & Agriculture Application
  14. Environmental Application
  15. GLOBAL: Projected Revenue by End-User (2020-2029; $Billions)
  16. Academic/Research Institutes & Laboratories
  17. Pharma & Biotech Companies
  18. Others


CHAPTER – 4: Key Regions Overview

  1. North America: Projected Revenue of Synthetic Biology Market (2020-2029; $Billions)
  2. Projected Revenue of Synthetic Biology Market in US
  3. Projected Revenue of Synthetic Biology Market in Canada
  4. Europe: Projected Revenue of Synthetic Biology Market (2020-2029; $Billions)
  5. Projected Revenue of Synthetic Biology Market in UK
  6. Projected Revenue of Synthetic Biology Market in Germany
  7. Projected Revenue of Synthetic Biology Market in France
  8. Projected Revenue of Synthetic Biology Market in Italy
  9. Projected Revenue of Synthetic Biology Market in Spain
  10. APAC: Projected Revenue of Synthetic Biology Market (2020-2029; $Billions)
  11. Projected Revenue of Synthetic Biology Market in Japan
  12. Projected Revenue of Synthetic Biology Market in China
  13. Projected Revenue of Synthetic Biology Market in South Korea
  14. Projected Revenue of Synthetic Biology Market in Australia
  15. Projected Revenue of Synthetic Biology Market in India
  16. Latin America: Projected Revenue of Synthetic Biology Market (2020-2029; $Billions)
  17. Projected Revenue of Synthetic Biology Market in Brazil
  18. Projected Revenue of Synthetic Biology Market in Mexico
  19. Projected Revenue of Synthetic Biology Market in Argentina
  20. Middle East & Africa: Projected Revenue of Synthetic Biology Market (2020-2029; $Billions)
  21. Projected Revenue of Synthetic Biology Market in Turkey
  22. Projected Revenue of Synthetic Biology Market in Saudi Arabia
  23. Projected Revenue of Synthetic Biology Market in South Africa


CHAPTER – 5: Synthetic Biology Market Prospects & Opportunities

  1. Synthetic Biology Market Opportunities & Trends
  2. Synthetic Biology Market Drivers
  3. Synthetic Biology Market Constraints


CHAPTER – 6: Synthetic BiologyIndustry Overview

  1. Synthetic Biology Market - Competitive Landscape
  2. Synthetic Biology Market – Key Vendor Profiles
  3. Synthetic Biology Market – Other Prominent Vendors
  4. Synthetic Biology Market - Key Strategic Recommendations


CHAPTER – 7: Appendix

  1. Research Methodology
  2. Abbreviations
  3. About Arizton

Select a license type that suits your business needs

Single User Licence

$2990.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$3500.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$4500.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

What are the key drivers of the global synthetic biology market?

Rising demand for DNA sequencing, the surge in synthetic biology investments driven by food and energy sectors, and the increasing number of start-ups boosting the demand are the key drivers of the global synthetic biology market.

How big is the global synthetic biology market?

The global synthetic biology market was valued at USD 15.20 billion in 2023 and is expected to reach USD 59.91 billion by 2029.

Which region dominates the global synthetic biology market?

North America dominates the global synthetic biology market.

What is the growth rate of the global synthetic biology market?

The global synthetic biology market is expected to grow at a CAGR of 25.68% during the forecast period.

Who are the major players in the global synthetic biology market?

Agilent Technologies, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific are the major players in the global synthetic biology market.